Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

103
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
103
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

80
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
80
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

52
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

80
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

57
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
57
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

68
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sitosterolemia misdiagnosed as homozygous familial hypercholesterolemia: A diagnostic challenge.

American journal of preventive cardiology·2026
Same author

Age-associated outcomes in cardiogenic shock supported with microaxial flow pumps.

Annals of intensive care·2026
Same author

Clinical impact of guideline-directed medical therapy in patients with left ventricular assist device: an international multicentre study.

ESC heart failure·2026
Same author

Determinants and outcomes of late electrical storm in patients supported by left ventricular assist device.

Heart rhythm·2026
Same author

Duration of heart failure as a determinant of outcomes after left ventricular assist device implantation: an international multicenter study.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Comparative accuracy of a predictive algorithm versus cardiologist assessment for 90-day readmission in decompensated chronic heart failure.

BMC cardiovascular disorders·2026

Related Experiment Video

Updated: Oct 5, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.6K

Takotsubo cardiomyopathy.

Anthony Matta1,2, Clement Delmas1, Francesco Campelo-Parada1

  • 1Department of Cardiology, Toulouse University Hospital, 31000 Toulouse, France.

Reviews in Cardiovascular Medicine
|January 29, 2022
PubMed
Summary

Takotsubo cardiomyopathy (TTC) is a heart condition causing temporary heart failure and abnormal heart wall motion. While typically benign, it can lead to serious complications and is diagnosed using imaging techniques.

Keywords:
Acute coronary syndromeApical ballooning syndromeCardiac MRIHeart failureTakotsubo cardiomyopathy

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.9K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.3K

Related Experiment Videos

Last Updated: Oct 5, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.6K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.9K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.3K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Takotsubo cardiomyopathy (TTC) is characterized by transient acute heart failure.
  • It involves regional wall motion abnormalities beyond single coronary artery distribution.
  • TTC is classified into apical, basal, mid-ventricular, and focal types.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and management of Takotsubo cardiomyopathy.
  • To highlight the role of sympathetic stimulation in TTC pathogenesis.
  • To outline diagnostic modalities and therapeutic approaches for TTC.

Main Methods:

  • Review of existing literature on Takotsubo cardiomyopathy.
  • Analysis of diagnostic tools including coronary angiography, left ventriculography, echocardiography, and cardiac MRI.
  • Evaluation of management strategies for TTC.

Main Results:

  • Sympathetic nerve stimulation and catecholamine storm are key in TTC pathogenesis.
  • The disease course is generally benign but can present with life-threatening complications.
  • Diagnosis relies on specific imaging and angiographic findings.

Conclusions:

  • Takotsubo cardiomyopathy is a distinct clinical entity requiring specific diagnostic approaches.
  • Management primarily involves conventional heart failure therapy, except in critical cases.
  • Understanding TTC pathogenesis is crucial for patient care and risk stratification.